BN Business News
Ajouter votre entreprise →
Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.

Énergie et environnement · 18/04/20052 min de lecture

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Traduction automatique locale · Langue originale de la source

Résumé

The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 20 and 21, 2005. Although the dates of the ACMUI public meeting remain April 20 and 21, as originally published in the February 28, 2005 notice (see 70 FR 9611), this notice is meant to alert interested parties that the time for the ACMUI's briefing to the Commission has changed. See heading below entitled "Date and Time for Commission Briefing" for details. A sample of agenda items to be discussed during the public sessions includes: (1) Status of Rulemaking: Pt. 35 Training and Experience; (2) Status and Update: Redefining Medical Events; (3) Case Experience in Using I-125 Seeds as Markers; (4) FDA Radiation Dose Limits for Human Research Subjects Using Certain Radiolabeled Drugs, and (5) Establishing Guidance on Exceeding Dose Limits for Members of the Public who would serve as Caregivers to Persons undergoing Radiopharmaceutical Therapy. To review the agenda, see http:// www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact [email protected]. Purpose: Discuss issues related to 10 CFR 35, Medical Use of Byproduct Material. Date and Time for

Langue originale de la source: Federal Register — Nuclear Regulatory CommissionOuvrir le communiqué original →

Explorer les analyses

Analyses business →